Active, not recruitingPhase 2NCT02923778
Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery
Studying Pleomorphic liposarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Steven I RobinsonMayo Clinic Cancer Center LAO
- Intervention
- Biopsy Procedure(procedure)
- Enrollment
- 40 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2026
Study locations (17)
- Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
- Mayo Clinic in Florida, Jacksonville, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
- Moffitt Cancer Center, Tampa, Florida, United States
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
- Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Siteman Cancer Center-South County, St Louis, Missouri, United States
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, United States
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
- Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
- M D Anderson Cancer Center, Houston, Texas, United States
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02923778 on ClinicalTrials.govOther trials for Pleomorphic liposarcoma
Additional recruiting or active studies for the same condition.